These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


286 related items for PubMed ID: 22868173

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U, Sgodda M, Warlich E, Ballmaier M, Schöler HR, Schambach A, Cantz T.
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [Abstract] [Full Text] [Related]

  • 5. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J, Chen T, Liu X, Jiang J, Li J, Li D, Liu XS, Li W, Kang J, Pei G.
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [Abstract] [Full Text] [Related]

  • 6. Overexpression Nanog activates pluripotent genes in porcine fetal fibroblasts and nuclear transfer embryos.
    Zhang L, Luo YB, Bou G, Kong QR, Huan YJ, Zhu J, Wang JY, Li H, Wang F, Shi YQ, Wei YC, Liu ZH.
    Anat Rec (Hoboken); 2011 Nov; 294(11):1809-17. PubMed ID: 21972213
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2--brief report.
    Ho PJ, Yen ML, Lin JD, Chen LS, Hu HI, Yeh CK, Peng CY, Lin CY, Yet SF, Yen BL.
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1905-7. PubMed ID: 20689077
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stem cells. A new year and a new era.
    Pera MF.
    Nature; 2008 Jan 10; 451(7175):135-6. PubMed ID: 18185576
    [No Abstract] [Full Text] [Related]

  • 17. Induction of pluripotency: from mouse to human.
    Zaehres H, Schöler HR.
    Cell; 2007 Nov 30; 131(5):834-5. PubMed ID: 18045526
    [Abstract] [Full Text] [Related]

  • 18. Emerging methods for preparing iPS cells.
    Miyazaki S, Yamamoto H, Miyoshi N, Takahashi H, Suzuki Y, Haraguchi N, Ishii H, Doki Y, Mori M.
    Jpn J Clin Oncol; 2012 Sep 30; 42(9):773-9. PubMed ID: 22826352
    [Abstract] [Full Text] [Related]

  • 19. Landmark approach to generating human stem cells.
    Daubman S.
    Circ Res; 2011 Jan 21; 108(2):161-3. PubMed ID: 21252149
    [No Abstract] [Full Text] [Related]

  • 20. Direct reprogramming 101.
    Takahashi K.
    Dev Growth Differ; 2010 Apr 21; 52(3):319-33. PubMed ID: 20298260
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.